Taiwan's Aprinoia Therapeutics raises $11m co-led by KTB Network, DCI Partners

Taiwan-based Aprinoia Therapeutics Inc, a clinical-stage neuroscience biotech company, said it has completed its $11 million Series B funding round co-led by Korea’s KTB Network and Japan’s DCI Partners.